First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

Abstract

Minimally invasive management of B3 lesions (except ADH and PT) with VAB continues to be appropriate as an alternative to first-line OE in most cases, but with more frequent surveillance, especially for LN.